Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 12.45
+0.54 (4.53%)
At close: Mar 27, 2026
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 8.37 billion as of March 27, 2026. Its market cap has increased by 73.88% in one year.
Market Cap
8.37B
Enterprise Value
6.05B
Revenue
681.17M
Ranking
n/a
PE Ratio
126.50
Stock Price
12.45
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 8.37B, a decrease of -3.90%. That is a compound annual growth rate of -0.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 8.01B | -8.46% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 12.86B |
| HBM Holdings | 10.18B |
| CStone Pharmaceuticals | 10.14B |
| Guangzhou Innogen Pharmaceutical Group | 9.79B |
| Shanghai Haohai Biological Technology | 9.19B |
| CARsgen Therapeutics Holdings | 8.89B |
| Lepu Biopharma | 8.88B |
| Alphamab Oncology | 7.83B |